Clinical Characteristics and Outcomes of Pheochromocytoma Crisis: a Literature Review of 200 Cases
Overview
Affiliations
Purpose: Pheochromocytoma crisis is a life-threatening endocrine emergency that requires prompt diagnosis and treatment. Because of its rarity, sudden onset, and lack of internationally uniform and validated diagnostic criteria, pheochromocytoma crisis remains to be fully clarified. Therefore, we aimed to describe the clinical characteristics and outcomes of pheochromocytoma crisis through a literature review.
Methods: We performed a systematic literature search of PubMed/MEDLINE database, Igaku-Chuo-Zasshi (Japanese database), and Google Scholar to identify case reports of pheochromocytoma crisis published until February 5, 2021. Information was extracted and analyzed from the literature that reported adequate individual patient data of pheochromocytoma crisis in English or Japanese. Cases were also termed as pheochromocytoma multisystem crisis (PMC) if patients had signs of hyperthermia, multiple organ failure, encephalopathy, and labile blood pressure.
Results: In the 200 cases of pheochromocytoma crisis identified from 187 articles, the mean patient age was 43.8 ± 15.5 years. The most common symptom was headache (39.5%). The heart was the most commonly damaged organ resulting from a complication of a pheochromocytoma crisis (99.0%), followed by the lungs (44.0%) and the kidney (21.5%). PMC accounted for 19.0% of all pheochromocytoma crisis cases. After excluding 12 cases with unknown survival statuses, the mortality rate was 13.8% (26/188 cases). Multivariable logistic regression analysis revealed that nausea and vomiting were significantly associated with a higher mortality rate.
Conclusion: Pheochromocytoma can present with different symptomatology, affecting different organ systems. Clinicians should be aware that patients with nausea or vomiting are at a higher risk of death because of pheochromocytoma crisis.
Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment.
Saavedra T J, Nati-Castillo H, Valderrama Cometa L, Rivera-Martinez W, Asprilla J, Castano-Giraldo C Front Endocrinol (Lausanne). 2024; 15:1433582.
PMID: 39735644 PMC: 11671257. DOI: 10.3389/fendo.2024.1433582.
Surgical anesthesia in a patient with a pheochromocytoma crisis supported by ECMO: a case report.
Chen M, Yan W, Yang Z, Hong T, Jin L, Cao D J Cardiothorac Surg. 2024; 19(1):674.
PMID: 39707397 PMC: 11660651. DOI: 10.1186/s13019-024-03177-w.
Guo J, Qiu Y, Zhang X, Qian Y, Xu J BMC Anesthesiol. 2024; 24(1):463.
PMID: 39701997 PMC: 11657772. DOI: 10.1186/s12871-024-02850-w.
Kaneshima H, Miura N, Tsuchiya A, Morita S, Nakagawa Y Cureus. 2024; 16(11):e73582.
PMID: 39677247 PMC: 11643415. DOI: 10.7759/cureus.73582.
Narayanaswamy G, Sarma D, Saikia U, Baro A, Bhuyan A J ASEAN Fed Endocr Soc. 2024; 39(2):48-53.
PMID: 39620189 PMC: 11604364. DOI: 10.15605/jafes.039.02.07.